166 related articles for article (PubMed ID: 26857460)
1. Metabolic/Proteomic Signature Defines Two Glioblastoma Subtypes With Different Clinical Outcome.
Marziali G; Signore M; Buccarelli M; Grande S; Palma A; Biffoni M; Rosi A; D'Alessandris QG; Martini M; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
Sci Rep; 2016 Feb; 6():21557. PubMed ID: 26857460
[TBL] [Abstract][Full Text] [Related]
2. A three-microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes.
Marziali G; Buccarelli M; Giuliani A; Ilari R; Grande S; Palma A; D'Alessandris QG; Martini M; Biffoni M; Pallini R; Ricci-Vitiani L
Mol Oncol; 2017 Sep; 11(9):1115-1129. PubMed ID: 28248456
[TBL] [Abstract][Full Text] [Related]
3. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
[TBL] [Abstract][Full Text] [Related]
4. (1) H NMR spectroscopy of glioblastoma stem-like cells identifies alpha-aminoadipate as a marker of tumor aggressiveness.
Rosi A; Ricci-Vitiani L; Biffoni M; Grande S; Luciani AM; Palma A; Runci D; Cappellari M; De Maria R; Guidoni L; Pallini R; Viti V
NMR Biomed; 2015 Mar; 28(3):317-26. PubMed ID: 25581615
[TBL] [Abstract][Full Text] [Related]
5. Comparison of glioma stem cells to neural stem cells from the adult human brain identifies dysregulated Wnt- signaling and a fingerprint associated with clinical outcome.
Sandberg CJ; Altschuler G; Jeong J; Strømme KK; Stangeland B; Murrell W; Grasmo-Wendler UH; Myklebost O; Helseth E; Vik-Mo EO; Hide W; Langmoen IA
Exp Cell Res; 2013 Aug; 319(14):2230-43. PubMed ID: 23791939
[TBL] [Abstract][Full Text] [Related]
6. Identification of microRNAs differentially expressed in glioblastoma stem-like cells and their association with patient survival.
Sana J; Busek P; Fadrus P; Besse A; Radova L; Vecera M; Reguli S; Stollinova Sromova L; Hilser M; Lipina R; Lakomy R; Kren L; Smrcka M; Sedo A; Slaby O
Sci Rep; 2018 Feb; 8(1):2836. PubMed ID: 29434344
[TBL] [Abstract][Full Text] [Related]
7. A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma.
Chai R; Zhang K; Wang K; Li G; Huang R; Zhao Z; Liu Y; Chen J
J Cancer Res Clin Oncol; 2018 Mar; 144(3):439-447. PubMed ID: 29299749
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal and Proneural Subtypes of Glioblastoma Disclose Branching Based on GSC Associated Signature.
Steponaitis G; Tamasauskas A
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066996
[TBL] [Abstract][Full Text] [Related]
9. 1H NMR detects different metabolic profiles in glioblastoma stem-like cells.
Guidoni L; Ricci-Vitiani L; Rosi A; Palma A; Grande S; Luciani AM; Pelacchi F; di Martino S; Colosimo C; Biffoni M; De Maria R; Pallini R; Viti V
NMR Biomed; 2014 Feb; 27(2):129-45. PubMed ID: 24142746
[TBL] [Abstract][Full Text] [Related]
10. Glioblastoma stem cells express non-canonical proteins and exclusive mesenchymal-like or non-mesenchymal-like protein signatures.
Babačić H; Galardi S; Umer HM; Hellström M; Uhrbom L; Maturi N; Cardinali D; Pellegatta S; Michienzi A; Trevisi G; Mangiola A; Lehtiö J; Ciafrè SA; Pernemalm M
Mol Oncol; 2023 Feb; 17(2):238-260. PubMed ID: 36495079
[TBL] [Abstract][Full Text] [Related]
11. The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells.
Galavotti S; Bartesaghi S; Faccenda D; Shaked-Rabi M; Sanzone S; McEvoy A; Dinsdale D; Condorelli F; Brandner S; Campanella M; Grose R; Jones C; Salomoni P
Oncogene; 2013 Feb; 32(6):699-712. PubMed ID: 22525272
[TBL] [Abstract][Full Text] [Related]
12. Coculture with astrocytes reduces the radiosensitivity of glioblastoma stem-like cells and identifies additional targets for radiosensitization.
Rath BH; Wahba A; Camphausen K; Tofilon PJ
Cancer Med; 2015 Nov; 4(11):1705-16. PubMed ID: 26518290
[TBL] [Abstract][Full Text] [Related]
13. An expression based REST signature predicts patient survival and therapeutic response for glioblastoma multiforme.
Liang J; Meng Q; Zhao W; Tong P; Li P; Zhao Y; Zhao X; Li H
Sci Rep; 2016 Oct; 6():34556. PubMed ID: 27698411
[TBL] [Abstract][Full Text] [Related]
14. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide.
Tso JL; Yang S; Menjivar JC; Yamada K; Zhang Y; Hong I; Bui Y; Stream A; McBride WH; Liau LM; Nelson SF; Cloughesy TF; Yong WH; Lai A; Tso CL
Mol Cancer; 2015 Nov; 14():189. PubMed ID: 26546412
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotypic characterization of human glioblastoma stem cells: correlation with clinical outcome.
Miconi G; Palumbo P; Dehcordi SR; La Torre C; Lombardi F; Evtoski Z; Cimini AM; Galzio R; Cifone MG; Cinque B
J Cell Biochem; 2015 May; 116(5):864-76. PubMed ID: 25559650
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive analysis of prognosis prediction models based on pathway‑level, gene‑level and clinical information for glioblastoma.
Liang R; Wang M; Zheng G; Zhu H; Zhi Y; Sun Z
Int J Mol Med; 2018 Oct; 42(4):1837-1846. PubMed ID: 30015853
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of MicroRNAs in patients with glioblastoma after concomitant chemoradiotherapy.
Park EC; Kim G; Jung J; Wang K; Lee S; Jeon SS; Lee ZW; Kim SI; Kim S; Oh YT; Shin JH; Jang HS; Choi BO; Kim GH
OMICS; 2013 May; 17(5):259-68. PubMed ID: 23586679
[TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
[TBL] [Abstract][Full Text] [Related]
20. Global analysis of H3K4me3 and H3K27me3 profiles in glioblastoma stem cells and identification of SLC17A7 as a bivalent tumor suppressor gene.
Lin B; Lee H; Yoon JG; Madan A; Wayner E; Tonning S; Hothi P; Schroeder B; Ulasov I; Foltz G; Hood L; Cobbs C
Oncotarget; 2015 Mar; 6(7):5369-81. PubMed ID: 25749033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
